Evaluation of an educational program on calcium and phosphorus metabolism for patients on hemodialysis;Avaliação de programa de ensino-aprendizagem sobre metabolismo de cálcio e fósforo para pacientes em hemodiálise

Revista da Escola de Enfermagem

Volumn 44, Issue 4, 2010, Pages 928-932

  de Araujo, Lílian Peres Righetto ^a   Figueiredo, Ana Elizabeth Prado Lima ^a   d'Avila, Domingos Otavio Lorenzoni ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Calcium; Health education; Patients; Phosphorus; Renal dialysis

Indexed keywords

CALCIUM; PHOSPHORUS;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEALTH CARE QUALITY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHOSPHORUS; PROGRAM EVALUATION; RENAL DIALYSIS; YOUNG ADULT;

EID: 78650465130     PISSN: 00806234     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0080-62342010000400010     Document Type: Article

References (20)

1. National Kidney Foundation. K/DOQI guidelines [text on the Internet]. [cited 2009 May 12]. Available from: http://www.kidney.org/professionals/KDOQI/guidelines.cfm
2. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31(4):607-17.
3. Ansell D, Feest T, Taylor H. Serum phosphate and dialysis mortality in 1998: a multi-centre study from the UK [abstract]. Nephrol Dial Transplant. 2000;15:A182.
4. Levin NW, Hulbert-Shearon TE, Strawderman RL. Which causes of death are related to hyperphosphatemia in hemodialysis (HD) patients? [abstract]. J Am Soc Nephrol. 1998;9:217A.
5. Delmez JA, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis. 1992;19(4):303-17.
6. Gullo A BM, Lima AFC, Silva MJP. Reflexões sobre comunicações na assistência de enfermagem aopaciente renal crônico. Rev Esc Enferm USP. 2000;34(2):202-8.
7. Zimmermann PR, Camey SA, Mari Jde J. A cohort study to assess the impact of depression on patients with kidney disease. Int J Psychiatry Med. 2006;36(4):457-68.
8. Anderson RJ, Kirk LM. Methods of improving patient compliance in chronic disease states. Arch Intern Med. 1982;142(9):1673-5.
9. a ed. Rio de Janeiro: Graal; 1989. Medicina popular e medicina científica: a legitimidade médica; p. 28-31.
10. Oaksford K, Oaksford M, Ashraf M, Fitzgibbon G. Comparing neuropsychological function before and during haemodialysis: a habituating selective deficit for prose recall. Br J Health Psychol. 2008;13(2):273-89.
11. Goldim JR. Indices de legibilidade de Flesch-Kincaid e de facilidade de leitura de Flesch [texto na Internet]. [citado 2009 maio 12]. Disponível em: http://www.ufrgs.br/bioetica/ilfk.htm
12. a ed. Rio de Janeiro: Medsi; 1996.
13. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1-201.
14. Nisio JM, Bazanelli AP, Kamimura MA, Lopes MGG, Ribeiro FSM, Vasselai P, et al. Impacto de um programa de educação nutricional no controle da hiperfosfatemia de pacientes em HD. J Bras Nefrol. 2007;29(3):152-7.
15. Shaw-Stuart NJ, Stuart A. The effect of an educational patient compliance program on serum phosphate levels in patients receiving hemodialysis. J Ren Nutr. 2000;10(2):80-4.
16. nd ed. New York: Guilford; 2002.
17. Gillis BP, Caggiula AW, Chiavacci AT, Coyne T, Doroshenko L, Milas NC, et al. Nutrition intervention program of the Modification of Diet in Renal Disease Study: a self-management approach. J Am Diet Assoc. 1995;95(11):1288-94.
18. Hörl WH. A need for an individualized approach to end-stage renal disease patients. Nephrol Dial Transplant. 2002;17 Suppl 6:17-21.
19. Sun CX, Chang KC, Chen SH, Chang CT, Wu MS. Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients. Ren Fail. 2008:30(1):57-62.
20. Karamandinou C, Clatworthy J, Weinman J, Horne R. A systematic review of the prevalence and determinants of nonadherence to phosphate binding medication in patients with end-stage renal disease. BMC Nephrol. 2008;9(2):1-10.